Download App

Log in to access Online Inquiry
Company Overview More
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin’s lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
CEO: Ricks, David A.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > LLY Eli Lilly and Co > Detailed Quotes

LLY Eli Lilly and Co

302.600+3.750+1.25%
Close 05/23 19:54 ET
302.000-0.6-0.20%
Post Mkt Price 05/23 19:24 ET
High
304.920
Open
300.600
Turnover
868.42M
Low
299.350
Pre Close
298.850
Volume
2.87M
Market Cap
287.52B
P/E(TTM)
44.96
52wk High
312.945
Shares
950.16M
P/E(Static)
49.44
52wk Low
193.944
Float Cap
273.78B
Bid/Ask %
-60.00%
Historical High
312.945
Shs Float
904.76M
Volume Ratio
0.89
Historical Low
17.601
Dividend TTM
3.53
Div Yield TTM
1600
P/B
30.81
Dividend LFY
1.17%
Div Yield LFY
528.75%
Turnover Ratio
0.32%
Amplitude
1.86%
Avg Price
302.203
Lot Size
1
Float Cap
273.78B
Bid/Ask %
-60.00%
Historical High
312.945
Shs Float
904.76M
Volume Ratio
0.89
Historical Low
17.601
Dividend TTM
3.53
P/B
30.81
Dividend LFY
1.17%
Turnover Ratio
0.32%
Amplitude
1.86%
Avg Price
302.203
Lot Size
1
Price Forecast

No Data

News

Comment